ChromoGenics publishes the annual report 2018
ChromoGenics publishes the annual report 2018
ChromoGenics annual report for 2018, in Swedish, is now available on https://www.chromogenics.com/investor-relations/ in pdf-format. The annual report can also be ordered in print from the company and distributed via post to shareholders on demand.
The Annual General Meeting will take place Wednesday May 15, 2019 at 14.00 CET in Advokatfirman Lindahl’s offices on Vaksalagatan 10, Uppsala. Complete notifications and documents will be available at https://www.chromogenics.com/investor-relations/and at the company at the time for the notice to AGM.
Contact:
Jerker Lundgren, CEO
Lars Ericsson, CFO and Head of Communications
Tel: +46 (0)18 430 0430
E-mail: info@chromogenics.com
Certified Adviser: G&W Fondkommission, e-mail: ca@gwkapital.se, tel.: +46 (0) 8 503 000 50
This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on 16 april, 2019, at 08:30 CET.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
About ChromoGenics
ChromoGenics offers dynamic glass with controllable heat- and light transmission and static glass with world leading performance. The company’s unique technology ConverLight® provides sustainable solar control for increased indoor comfort and energy efficiency. ConverLight also contributes to Green Building certifications. In 2016 the company started commercial sales to real estate projects in Scandinavia.
ChromoGenics is located in Uppsala, Sweden, and the technology is derived from the world leading research center at Ångström Laboratory at Uppsala University. The plant has been partly financed by a conditional loan from the Swedish Energy Agency. ChromoGenics share (CHRO) is listed on Nasdaq First North Stockholm with G&W Fondkommission as Certified Adviser. www.chromogenics.com
Tags: